Cargando…
Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown diverse life-threatening effects, most of which are considered short-term. In addition to its short-term effects, which has claimed many millions of lives since 2019, the long-term complications of this virus are still under inve...
Autores principales: | Jahankhani, Kasra, Ahangari, Fatemeh, Adcock, Ian M., Mortaz, Esmaeil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM).
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202899/ https://www.ncbi.nlm.nih.gov/pubmed/37230238 http://dx.doi.org/10.1016/j.biochi.2023.05.014 |
Ejemplares similares
-
The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
por: Alipoor, Shamila D., et al.
Publicado: (2021) -
Limitation of COPD Studies in Animal Modeling
por: Mortaz, Esmaeil, et al.
Publicado: (2012) -
Role of P2X7 Receptors in Release of IL-1β: A Possible Mediator of Pulmonary Inflammation
por: Mortaz, Esmaeil, et al.
Publicado: (2012) -
Is There an Ending in Insight for COVID-19?
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)